Latest Ubiquitin Research

Explore groundbreaking studies, reviews, and discoveries in ubiquitination pathways

Research Articles

When a Promising Treatment Fails: Lovastatin Shows No Benefit for Angelman Syndrome Symptoms in Mouse Model

Research shows lovastatin fails to improve Angelman syndrome symptoms in mouse models, highlighting challenges in neurological disorder treatment development.

Emily Perry
Oct 22, 2025

Catching a Killer: How Protein Sleuthing Reveals ALS Triggers

Discover how proteogenomics is revolutionizing ALS research by revealing how CCNF gene mutations trigger cell death pathways in motor neurons.

Anna Long
Oct 22, 2025

The Uterine Symphony: How Tiny Molecular Maestros Orchestrate Your Cycle

Discover how SUMO-associated proteins in the mouse endometrium are dynamically regulated by ovarian hormones throughout the estrous cycle.

Emma Hayes
Oct 22, 2025

Cellular "Janitors" & "Assassins": How the Ubiquitin-Proteasome System Became a New Anti-Cancer Weapon

Explore how the ubiquitin-proteasome system, the cell's protein degradation machinery, is being targeted for innovative cancer therapies like proteasome inhibitors and PROTACs.

Jackson Simmons
Oct 22, 2025

The Secret World in a Cottonseed: How Geneticists Are Unlocking Nature's Hidden Blueprints

Discover how QTL analysis reveals the genetic secrets of cottonseed traits and their impact on cotton breeding and agriculture.

Penelope Butler
Oct 22, 2025

Unlocking New Lung Cancer Treatments: The USP27X Story

Discover how USP27X, a deubiquitinating enzyme, is emerging as a promising drug target for lung cancer treatment through innovative research and validation experiments.

Liam Carter
Oct 21, 2025

SNIPER(ER): The Molecular Assassins Revolutionizing Breast Cancer Treatment

Explore how SNIPER(ER) molecules target and degrade ERα proteins in breast cancer treatment through innovative protein degradation technology.

Emma Hayes
Oct 21, 2025

UBX-306: The Molecular Demolition Crew Revolutionizing Cancer Immunotherapy

Discover how UBX-306, a novel HPK1 degrader using PROTAC technology, is revolutionizing cancer immunotherapy by eliminating immune system brakes at the molecular level.

Hannah Simmons
Oct 21, 2025

The Guardian's Betrayal: When the Body's Cancer Defense Turns Rogue

Explore how mutations in the MDM2 protein can subvert the body's natural cancer defenses and contribute to tumor development.

Caroline Ward
Oct 21, 2025

The Eye as a Window: How Huntington's Disease Changes the Retina

Could an eye test one day help predict a brain disorder? New research suggests the answer might be staring back at us.

Joseph James
Oct 21, 2025

Popular Articles